MNK $34.69 +0.55 (1.61%)
Mallinckrodt Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $22.79 which is 52.22% below the stock price of $34.69.
200 Day Moving Average
The 200 Day Moving Average is at 19.50 which is 77.90% below the stock price of $34.69.
Because both the 50 DMA and 200 DMA are below the current stock price, this can be considered a bullish technical indicator.
Since the stock price is very far from both moving averages, a price retracement towards the moving averages should not be unexpected.
MNK Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $34.69.
The Year To Date (YTD) return is +47.49%.
52 Week Low
The 52 Week Low stock price is $11.65 set on Fri, May 4, 2018 which is 108 days ago.
The current price per share is 197.77% above the 52 week low.
52 Week High
The 52 Week High stock price is $41.70 set on Fri, Sep 1, 2017 which is 353 days ago.
The current price per share is -16.81% below the 52 week high.
All Time High
The All Time High stock price is $134.26 set on Mon, Mar 23, 2015 which is 1,246 days ago.
The current price per share is -74.16% below the all time high.
Below is the EPS, P/E Ratio and Earnings Date.
The Earnings Per Share (EPS) is $18.35.
The Price To Earnings (P/E) Ratio is 1.63.
Mallinckrodt has a relatively low price to earnings ratio compared to the overal S&P 500 average, which is about 25%.
Some investors look for very low p/e stocks with the hopes of investing in an undervalued stock. Of course, this is just one factor to consider.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Mallinckrodt PLC was Tue, May 8, 2018.
Since this earnings release 104 days ago, the stock price is up by +171.44%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Tue, Aug 7, 2018, which was 13 days ago.
Since this earnings date, the stock price is up by +42.46%.
Below is important Dividend information.
MNK currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.
Below are other Biotech & Pharma stocks as Mallinckrodt.
MNK Company Profile
Learn more about Mallinckrodt.
Mallinckrodt PLC is a Health Care stock that trades on the NYSE and has a market capitalization of $2.84 Billion.
Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.
Spend a few minutes browsing the Mallinckrodt PLC, web site at http://www.mallinckrodt.com.